Median Survival Time and Significance of Prognostic Factors for PFS
| Univariate | Multivariate | |||
| Variable | P | Median (mo) | P | Hazard ratio (95% confidence interval) |
| Age (y) | 0.002 | |||
| ≤60 | 6.8 | |||
| >60 | 10.2 | 0.001 | 0.59 (0.42–0.81) | |
| Sex | 0.568 | |||
| Men | 7.2 | |||
| Women | 7.7 | |||
| Etiology | 0.198 | |||
| HBV | 7.2 | |||
| HCV | 11.8 | |||
| Alcohol | 21.2 | |||
| Other | 7.5 | |||
| Child–Pugh classification | 0.902 | |||
| A | 7.5 | |||
| B | 7.9 | |||
| Treatment | 0.054 | |||
| TACE | 7.2 | |||
| CCRT | 9.1 | |||
| Tumor size (cm) | 0.022 | |||
| ≤6.0 | 8.8 | |||
| >6.0 | 6.5 | 0.356 | ||
| Tumor number | 0.144 | |||
| Single | 7.7 | |||
| Multiple | 7.2 | |||
| Portal vein thrombosis | 0.029 | |||
| Absence | 9.2 | |||
| Presence | 6.5 | 0.313 | ||
| Serum AFP (ng/dL) | 0.969 | |||
| ≤500.0 | 7.2 | |||
| >500.0 | 7.7 | |||
| TLR | 0.014 | |||
| ≤2.0 | 9.8 | |||
| >2.0 | 6.2 | 0.009 | 1.55 (1.12–2.15) | |
HBV = hepatitis B virus; HCV = hepatitis C virus.